Psoriasis treatment that includes the immunosuppressant cyclosporin along with psoralen and ultraviolet A (PUVA) light therapy is associated with a significantly increased risk of squamous cell cancer of the skin, according to a new report.
Psoriasis treatment that includes the immunosuppressant cyclosporin along with psoralen and ultraviolet A (PUVA) light therapy is associated with a significantly increased risk of squamous cell cancer of the skin, according to a new report.